Styrene

Styrene

SCHEMBL1905281

C=Cc1ccccc1.CC=C(C)C(=O)O.CCCCC=CC(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.40
PTPN1 P18031 1/20 0.38
LMNA P02545 1/20 0.36
TSHR P16473 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HDAC3 O15379 2/20 0.36
EGFR P00533 1/20 0.36
BID P55957 3/20 0.36
BCL2L1 Q07817 3/20 0.36
MCL1 Q07820 3/20 0.36
BAK1 Q16611 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 1/20 0.35
SOAT2 O75908 1/20 0.35
SOAT1 P35610 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL8352287 0.85 AKR1C3 (0.42) AKR1C3LMNATSHRALDH1A1HDAC3
Styrene SCHEMBL7550251 0.83 AKR1C3 (0.52) AKR1C3LMNATSHRALDH1A1HDAC3
SCHEMBL6519004 0.83 PTPN1 (0.50) PTPN1LMNACYP1A2CYP2C9CYP2C19
Styrene SCHEMBL3141180 0.81 AKR1C3 (0.46) AKR1C3LMNATSHRALDH1A1HDAC3
Styrene SCHEMBL393960 0.81 AKR1C3 (0.46) AKR1C3LMNATSHRALDH1A1HDAC3
Methacrylic Acid SCHEMBL7949433 0.81 PTPN1 (0.45) PTPN1LMNAALDH1A1CYP1A2CYP2C9
Styrene SCHEMBL2042273 0.80 AKR1C3 (0.42) AKR1C3LMNATSHRALDH1A1HDAC3
Styrene SCHEMBL8206619 0.80 AKR1C3 (0.42) AKR1C3LMNATSHRALDH1A1HDAC3
Styrene SCHEMBL238869 0.80 AKR1C3 (0.59) AKR1C3LMNATSHRALDH1A1HDAC3
Styrene SCHEMBL134355 0.80 AKR1C3 (0.59) AKR1C3LMNATSHRALDH1A1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7935769-B2 Method for preparing a living polymer comprising methacrylic and/or methacrylate units ARKEMA FRANCE (FR) 2011-05-03 US disclosed
US-20080306169-A1 Method For Preparing a Living Polymer Comprising Methacrylic and/or Methacrylate Units ARKEMA FRANCE (FR) 2008-12-11 US disclosed
US-5264527-A Block copolymerization using vinylaromatics, methacrylates or acyclics ELF ATOCHEM S.A. (FR) 1993-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306169-A1 Method For Preparing a Living Polymer Comprising Methacrylic and/or Methacrylate Units MMAB, ALKBH2, ALKBH3 AKR1C3 586/4885PTPN1 2851/4885LMNA 964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.